secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2025-02-24T23:59:59+00:00
Accession:  0001829126-25-001180
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclacel amends stock purchase agreement with interim CEO for up to $8M equity line; adds 6-month lock-up
--------------------------------------------------------------------------------

- Purchase price amended to greater of closing bid at signing or prior to each purchase date.
- Added 6-month lock-up on any Shares issued under the agreement.
- Company retains right to direct David Lazar to buy up to $8,000,000 of common stock through Sep 30, 2026.
- Shares issued in reliance on exemptions under Securities Act Section 4(a)(2) and Regulation S or D.
- Lazar is interim CEO; lock-up applies for six months from issuance date of each tranche.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000182912625001180/0001829126-25-001180-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000182912625001180/cyclacel_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-25-001180

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer